Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts

Study ID: NCT03974217
Start Date: 2019-08-01
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Talazoparib

Decitabine

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Botensilimab and Balstilimab Optimization in Colorectal Cancer

Study ID: NCT06268015
Start Date: 2024-11-18
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

Botensilimab

Balstilimab

Oxaliplatin

Leucovorin

Fluorouracil

bevacizumab

panitumumab

Sponsor

Nicholas DeVito, MD

Source: clinicaltrials.gov

Share:
Add to list

Centralized Screening Unit (CSU) at Montefiore-Einstein

Study ID: NCT06284408
Start Date: 2025-02-24
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

9460

Intervention / Treatment

Centralized Screening Unit Implementation

Sponsor

Albert Einstein College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Molecular and Genetic Analysis of Lung Cancer

Study ID: NCT03029325
Start Date: 1993-06
End Date: 2026-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

15000

Intervention / Treatment
Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Study ID: NCT05986240
Start Date: 2024-05-08
End Date: 2030-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

38

Intervention / Treatment

Danvatirsen

Danvatirsen + Venetoclax

Sponsor

Montefiore Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Study ID: NCT05987189
Start Date: 2023-10-18
End Date: 2025-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

miLungDx

Sponsor

Hummingbird Diagnostics

Source: clinicaltrials.gov

Share:
Add to list

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Study ID: NCT05540340
Start Date: 2022-09-09
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

Pharmacokinetics

Pharmacokinetics

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Study ID: NCT06999187
Start Date: 2025-06-03
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

96

Intervention / Treatment

DR-0202

Sponsor

Dren Bio

Source: clinicaltrials.gov

Share:
Add to list

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

Study ID: NCT06086522
Start Date: 2023-11-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

54

Intervention / Treatment

QN-302

Sponsor

Qualigen Theraputics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Study ID: NCT06664151
Start Date: 2024-11-26
End Date: 2026-08-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

25

Intervention / Treatment

Fluzone Trivalent

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list